Related Experiment Video
Updated: Oct 2, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
The mousetrap: what we can learn when the mouse model does not mimic the human disease
Sarah H Elsea1, Rebecca E Lucas
1Department of Zoology, Michigan State University, East Lansing, MI, USA.
Abstract:
In recent years, mouse models for human metabolic diseases have become commonplace because the information gained from in vivo study of biochemical pathways is invaluable, and many metabolic diseases are relatively easy to recreate in mice through gene knockout technology in embryonic stem cells. In certain cases, however, the knockout mice may reproduce only some of the human disease phenotype, may be more severely affected than human cases, or may have no clinical phenotype at all. Under these circumstances, the disease pathology can become more complex, causing the researcher to evaluate basic differences in mouse and human biology as well as questions of genetic background, alternate pathways, and possible gene interactions. This review is a brief analysis of gene knockout models for Lesch-Nyhan syndrome, Lowe syndrome, X-linked adrenoleukodystrophy, Fabry disease, galactosemia, glycogen storage disease type II, metachromatic leukodystrophy, and Tay-Sachs disease, which produce a biochemical model of disease but often do not reproduce clinical symptoms. These mice may be useful for studying the biochemical and physiological pathways in which certain metabolites function toward embryonic and fetal development, as well as specific functions in various organs, and they may provide an inexpensive and useful model system for development of new therapeutic techniques.
Insights
Mouse models for human metabolic diseases are valuable for studying biochemical pathways. However, they often lack clinical symptoms, necessitating further research into mouse and human biological differences for therapeutic development.
Area of Science:
- Biomedical research
- Genetics and genomics
- Translational medicine
Background:
- Mouse models are widely used for studying human metabolic diseases.
- Gene knockout technology in embryonic stem cells facilitates disease recreation in mice.
- However, mouse models may not fully replicate human disease phenotypes, presenting challenges in research.
Purpose of the Study:
- To analyze gene knockout mouse models for specific human metabolic diseases.
- To highlight the discrepancies between biochemical and clinical phenotypes in these models.
- To explore the utility of these models for understanding disease mechanisms and developing therapies.
Main Methods:
- Review of existing literature on gene knockout mouse models for Lesch-Nyhan syndrome, Lowe syndrome, X-linked adrenoleukodystrophy, Fabry disease, galactosemia, glycogen storage disease type II, metachromatic leukodystrophy, and Tay-Sachs disease.
- Analysis of the phenotypes, both biochemical and clinical, observed in these mouse models.
- Evaluation of the biological differences between mice and humans that may contribute to phenotypic discrepancies.
Main Results:
- Gene knockout mouse models often successfully replicate the biochemical pathways of human metabolic diseases.
- These models frequently fail to reproduce the full clinical symptoms observed in human patients.
- Observed phenotypes in mice can range from partial to absent, or even be more severe than in humans.
Conclusions:
- Despite limitations in clinical phenotype replication, gene knockout mice are valuable for studying metabolic pathways and metabolite functions.
- These models can aid in understanding embryonic/fetal development and organ-specific functions.
- Mouse models offer a cost-effective platform for developing novel therapeutic strategies for metabolic diseases.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
In-vitro Mutagenesis (Gene Knockouts)
